Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Squalamine Lactate in Macular Edema secondary to RVO
NCT02614937Phase 2Completed
- Sponsor
- Ohr Pharmaceutical, Inc.
- Start
- Apr 2013
- Primary completion
- Dec 2014
01
Overview
A Phase 2 trial of squalamine in retinal vein occlusion (RVO), sponsored by Ohr Pharmaceutical, Inc.. Started Apr 2013; status: completed.
02
Drugs
squalamine
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT02614937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614937.